Kymera Therapeutics Inc
Biotechnology
Healthcare
KYMR
80.15 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
51.14
52 week high
52.40
high
51.16
52 week low
0.00
previous Close
51.01
P/E ratio
market cap
3.07 B
div yield
0
net profit margin
0.00 %
296.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top